Financials in USD. Standardized financial statements.
A compact view of how Syros Pharmaceuticals, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $9.94M | $14.88M | $23.49M | $15.09M | $1.98M | $2.05M | $1.10M | $317,000 | $317,000 | $0 |
| Revenue Growth? | -33.2% | -36.6% | +55.6% | +661.5% | -3.3% | +86.2% | +247.3% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $2.25M | $2.97M | $0 | $0 | $0 | $0 | $1.53M | $0 | $602,000 | $0 |
| Gross Profit? | $7.68M | $11.91M | $23.49M | $15.09M | $1.98M | $2.05M | -$426,000 | $317,000 | -$285,000 | $0 |
| Gross Margin? | +77.3% | +80.1% | +100.0% | +100.0% | +100.0% | +100.0% | -38.7% | +100.0% | -89.9% | 0.0% |
| Operating Expenses? | $30.77M | $38.81M | $122.91M | $97.39M | $79.72M | $66.35M | $55.79M | $48.28M | $30.14M | $13.44M |
| Operating Income? | -$128.99M | -$135.87M | -$99.42M | -$82.30M | -$77.74M | -$64.30M | -$54.69M | -$47.96M | -$29.82M | -$13.44M |
| EBITDA? | -$157.19M | -$87.55M | -$79.63M | -$79.21M | -$72.72M | -$60.67M | -$53.16M | -$46.69M | -$29.22M | -$13.18M |
| Income Before Tax | -$164.57M | -$94.65M | -$86.56M | -$84.04M | -$75.44M | -$62.28M | -$54.01M | -$47.74M | -$29.82M | -$13.43M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$164.57M | -$94.65M | -$86.56M | -$84.04M | -$75.44M | -$62.28M | -$54.01M | -$47.74M | -$29.82M | -$13.43M |
| EPS? | $-5.81 | $-7.49 | $-13.84 | $-18.25 | $-18.76 | $-19.07 | $-21.26 | $-37.60 | $-120.45 | $-54.25 |
| Diluted EPS? | $-5.81 | $-7.49 | $-13.84 | $-18.25 | $-18.76 | $-19.07 | $-21.26 | $-37.60 | $-120.45 | $-54.25 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality